| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 2.05e-06 | 5 | 119 | 3 | GO:0061628 | |
| GeneOntologyMolecularFunction | alpha-1,3-mannosyltransferase activity | 1.05e-04 | 3 | 119 | 2 | GO:0000033 | |
| GeneOntologyMolecularFunction | synaptic receptor adaptor activity | 2.10e-04 | 4 | 119 | 2 | GO:0030160 | |
| GeneOntologyMolecularFunction | signaling receptor complex adaptor activity | 3.01e-04 | 54 | 119 | 4 | GO:0030159 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 4.24e-04 | 59 | 119 | 4 | GO:1901505 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 5.65e-04 | 238 | 119 | 7 | GO:0016747 | |
| Domain | TFIID_sub1_DUF3591 | 4.03e-05 | 2 | 119 | 2 | IPR022591 | |
| Domain | TBP-binding | 4.03e-05 | 2 | 119 | 2 | PF09247 | |
| Domain | NCKAP5_C | 4.03e-05 | 2 | 119 | 2 | IPR032769 | |
| Domain | DUF3591 | 4.03e-05 | 2 | 119 | 2 | PF12157 | |
| Domain | Nckap5l | 4.03e-05 | 2 | 119 | 2 | IPR026163 | |
| Domain | NCKAP5 | 4.03e-05 | 2 | 119 | 2 | PF15246 | |
| Domain | TAF_II_230-bd | 4.03e-05 | 2 | 119 | 2 | IPR009067 | |
| Domain | - | 4.03e-05 | 2 | 119 | 2 | 1.10.1100.10 | |
| Domain | TAF1_animal | 4.03e-05 | 2 | 119 | 2 | IPR011177 | |
| Domain | SH3_2 | 2.23e-04 | 86 | 119 | 5 | PF07653 | |
| Domain | SH3_2 | 2.23e-04 | 86 | 119 | 5 | IPR011511 | |
| Domain | FERM_f0 | 2.40e-04 | 4 | 119 | 2 | PF16511 | |
| Domain | FERM_f0 | 2.40e-04 | 4 | 119 | 2 | IPR032425 | |
| Domain | Sugar_P_trans_dom | 1.75e-03 | 10 | 119 | 2 | IPR004853 | |
| Domain | TPT | 1.75e-03 | 10 | 119 | 2 | PF03151 | |
| Domain | - | 1.79e-03 | 81 | 119 | 4 | 3.90.550.10 | |
| Domain | SAM | 2.42e-03 | 88 | 119 | 4 | SM00454 | |
| Domain | Nucleotide-diphossugar_trans | 2.42e-03 | 88 | 119 | 4 | IPR029044 | |
| Domain | Oxysterol-bd_CS | 2.55e-03 | 12 | 119 | 2 | IPR018494 | |
| Domain | Oxysterol_BP | 2.55e-03 | 12 | 119 | 2 | PF01237 | |
| Domain | Oxysterol-bd | 2.55e-03 | 12 | 119 | 2 | IPR000648 | |
| Domain | OSBP | 2.55e-03 | 12 | 119 | 2 | PS01013 | |
| Domain | SAM_DOMAIN | 3.19e-03 | 95 | 119 | 4 | PS50105 | |
| Domain | SAM | 3.44e-03 | 97 | 119 | 4 | IPR001660 | |
| Domain | - | 4.72e-03 | 106 | 119 | 4 | 1.10.150.50 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCC3 PNPLA2 SH2B3 HECTD4 EXTL3 MED13L ZDHHC8 FANCA CCDC142 STK10 SLC7A1 SH3PXD2B ARAP3 PI4KA CHD5 NAV1 ZER1 GCN1 | 1.05e-07 | 1105 | 126 | 18 | 35748872 |
| Pubmed | TNIK DLGAP2 ASXL1 SASH1 NCKAP5 EXTL3 SHANK3 FANCA BRCA2 RPL13 | 3.66e-07 | 329 | 126 | 10 | 17474147 | |
| Pubmed | SHANK1 LAMA4 NCKAP5 SYNPO EXTL3 NCKAP5L SLC9A1 NAV1 PAK3 TAF1 GCN1 | 1.70e-06 | 486 | 126 | 11 | 20936779 | |
| Pubmed | SHANK1 TNIK DLGAP2 WDR7 HECTD4 SYNPO TRIP11 SHANK3 SH3PXD2B PI4KA NAT10 NT5C2 NAV1 PAK3 CDH2 | 2.28e-06 | 963 | 126 | 15 | 28671696 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | TNIK ABCC3 NECTIN3 ZDHHC8 MTMR10 STK10 ZDHHC20 SLC7A1 SLC9A1 PI4KA NAV1 | 7.61e-06 | 569 | 126 | 11 | 30639242 |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 28104815 | ||
| Pubmed | Developmental impaired Akt signaling in the Shank1 and Shank3 double knock-out mice. | 1.30e-05 | 2 | 126 | 2 | 33402706 | |
| Pubmed | Genetic variants in fanconi anemia pathway genes BRCA2 and FANCA predict melanoma survival. | 1.30e-05 | 2 | 126 | 2 | 25243787 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 38804708 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 10070062 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 22842574 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 27571988 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 34403156 | ||
| Pubmed | 1.90e-05 | 225 | 126 | 7 | 12168954 | ||
| Pubmed | 2.51e-05 | 16 | 126 | 3 | 27760317 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 10806096 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 28345660 | ||
| Pubmed | The FANC/BRCA Pathway Releases Replication Blockades by Eliminating DNA Interstrand Cross-Links. | 3.90e-05 | 3 | 126 | 2 | 32466131 | |
| Pubmed | USP8 Deubiquitinates SHANK3 to Control Synapse Density and SHANK3 Activity-Dependent Protein Levels. | 3.90e-05 | 3 | 126 | 2 | 29735556 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 16822332 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 11509555 | ||
| Pubmed | Translational neurobiology in Shank mutant mice--model systems for neuropsychiatric disorders. | 3.90e-05 | 3 | 126 | 2 | 25917711 | |
| Pubmed | The Fanconi Anemia Pathway Protects Genome Integrity from R-loops. | 3.90e-05 | 3 | 126 | 2 | 26584049 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 23583105 | ||
| Pubmed | Changes in protein expression due to deleterious mutations in the FA/BRCA pathway. | 3.90e-05 | 3 | 126 | 2 | 17977515 | |
| Pubmed | TAFII55 binding to TAFII250 inhibits its acetyltransferase activity. | 3.90e-05 | 3 | 126 | 2 | 11592977 | |
| Pubmed | TLR7/8 stress response drives histiocytosis in SLC29A3 disorders. | 3.90e-05 | 3 | 126 | 2 | 37462944 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 12217962 | ||
| Pubmed | TAF7: a possible transcription initiation check-point regulator. | 3.90e-05 | 3 | 126 | 2 | 16407123 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 26819149 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 32564287 | ||
| Pubmed | Akirin2 is essential for the formation of the cerebral cortex. | 4.31e-05 | 19 | 126 | 3 | 27871306 | |
| Pubmed | BICD2 SFXN4 WDR7 UGGT1 NECTIN3 TRIP11 ZDHHC20 SLC7A1 SLC9A1 TOMM40 SDC2 MFSD10 RPL13 | 4.41e-05 | 952 | 126 | 13 | 38569033 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 7.31e-05 | 377 | 126 | 8 | 38117590 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 7.76e-05 | 281 | 126 | 7 | 28706196 | |
| Pubmed | 7.78e-05 | 4 | 126 | 2 | 23897824 | ||
| Pubmed | 7.78e-05 | 4 | 126 | 2 | 20368279 | ||
| Pubmed | Hematopoietic dysfunction in a mouse model for Fanconi anemia group D1. | 7.78e-05 | 4 | 126 | 2 | 16859999 | |
| Pubmed | 7.78e-05 | 4 | 126 | 2 | 12686612 | ||
| Pubmed | S-acylation controls SARS-CoV-2 membrane lipid organization and enhances infectivity. | 7.78e-05 | 4 | 126 | 2 | 34599882 | |
| Pubmed | Congenital disorders of glycosylation: a booming chapter of pediatrics. | 7.78e-05 | 4 | 126 | 2 | 15273506 | |
| Pubmed | 7.78e-05 | 4 | 126 | 2 | 12626503 | ||
| Pubmed | Congenital disorders of glycosylation (CDG): update and new developments. | 7.78e-05 | 4 | 126 | 2 | 15272470 | |
| Pubmed | WDR7 TRIP11 ARHGEF15 CLPB BRCA2 PI4KA MDC1 NAT10 INPP5J RPL13 MAP3K19 | 9.83e-05 | 754 | 126 | 11 | 35906200 | |
| Pubmed | 1.24e-04 | 407 | 126 | 8 | 12693553 | ||
| Pubmed | 1.29e-04 | 5 | 126 | 2 | 16606358 | ||
| Pubmed | BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotype. | 1.29e-04 | 5 | 126 | 2 | 37549632 | |
| Pubmed | The insulin receptor substrate IRSp53 links postsynaptic shank1 to the small G-protein cdc42. | 1.29e-04 | 5 | 126 | 2 | 12504591 | |
| Pubmed | 1.29e-04 | 5 | 126 | 2 | 23038782 | ||
| Pubmed | Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2. | 1.29e-04 | 5 | 126 | 2 | 16621732 | |
| Pubmed | The insulin receptor substrate of 53 kDa (IRSp53) limits hippocampal synaptic plasticity. | 1.58e-04 | 29 | 126 | 3 | 19208628 | |
| Pubmed | FANCA and FANCC modulate TLR and p38 MAPK-dependent expression of IL-1β in macrophages. | 1.93e-04 | 6 | 126 | 2 | 24046015 | |
| Pubmed | FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3. | 1.93e-04 | 6 | 126 | 2 | 18212739 | |
| Pubmed | 1.93e-04 | 6 | 126 | 2 | 20450923 | ||
| Pubmed | 1.93e-04 | 6 | 126 | 2 | 16314316 | ||
| Pubmed | 1.93e-04 | 6 | 126 | 2 | 19959467 | ||
| Pubmed | Essential roles for the splicing regulator nSR100/SRRM4 during nervous system development. | 1.94e-04 | 31 | 126 | 3 | 25838543 | |
| Pubmed | 1.94e-04 | 31 | 126 | 3 | 19690177 | ||
| Pubmed | 2.70e-04 | 7 | 126 | 2 | 10481074 | ||
| Pubmed | Direct interaction of GluRdelta2 with Shank scaffold proteins in cerebellar Purkinje cells. | 2.70e-04 | 7 | 126 | 2 | 15207857 | |
| Pubmed | Genome-wide scan of copy number variation in late-onset Alzheimer's disease. | 2.70e-04 | 7 | 126 | 2 | 20061627 | |
| Pubmed | 2.70e-04 | 7 | 126 | 2 | 10527873 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | 3.00e-04 | 719 | 126 | 10 | 35337019 | |
| Pubmed | Conservation of position and exclusive expression of mouse Xist from the inactive X chromosome. | 3.59e-04 | 8 | 126 | 2 | 2034279 | |
| Pubmed | The G protein-coupled receptor CL1 interacts directly with proteins of the Shank family. | 3.59e-04 | 8 | 126 | 2 | 10958799 | |
| Pubmed | 3.59e-04 | 8 | 126 | 2 | 19640847 | ||
| Pubmed | Physical mapping of 2000 kb of the mouse X chromosome in the vicinity of the Xist locus. | 3.59e-04 | 8 | 126 | 2 | 8468051 | |
| Pubmed | Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia. | 3.59e-04 | 8 | 126 | 2 | 25048004 | |
| Pubmed | Genetic mapping in the region of the mouse X-inactivation center. | 3.59e-04 | 8 | 126 | 2 | 1974879 | |
| Pubmed | Deletion of Prl7d1 causes placental defects at mid-pregnancy in mice. | 3.59e-04 | 8 | 126 | 2 | 31012985 | |
| Pubmed | 3.59e-04 | 8 | 126 | 2 | 30319350 | ||
| Pubmed | High-density molecular map of the central span of the mouse X chromosome. | 3.59e-04 | 8 | 126 | 2 | 1675191 | |
| Pubmed | 4.61e-04 | 9 | 126 | 2 | 23931996 | ||
| Pubmed | 4.61e-04 | 9 | 126 | 2 | 12665565 | ||
| Pubmed | 4.61e-04 | 9 | 126 | 2 | 26269593 | ||
| Pubmed | Cloning and characterization of a new human Xq13 gene, encoding a putative helicase. | 4.61e-04 | 9 | 126 | 2 | 7874112 | |
| Pubmed | 4.61e-04 | 9 | 126 | 2 | 9751712 | ||
| Pubmed | FBXL13 directs the proteolysis of CEP192 to regulate centrosome homeostasis and cell migration. | 4.81e-04 | 42 | 126 | 3 | 29348145 | |
| Pubmed | 5.71e-04 | 104 | 126 | 4 | 10470851 | ||
| Pubmed | Contacts between the commissural axons and the floor plate cells are mediated by nectins. | 5.75e-04 | 10 | 126 | 2 | 15328010 | |
| Pubmed | 5.75e-04 | 10 | 126 | 2 | 2055107 | ||
| Pubmed | Large-scale structural analysis of the classical human protein tyrosine phosphatome. | 6.70e-04 | 47 | 126 | 3 | 19167335 | |
| Pubmed | Characterization of a murine gene expressed from the inactive X chromosome. | 7.01e-04 | 11 | 126 | 2 | 2034278 | |
| Pubmed | Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin. | 7.01e-04 | 11 | 126 | 2 | 11435469 | |
| Pubmed | SHANK proteins limit integrin activation by directly interacting with Rap1 and R-Ras. | 7.01e-04 | 11 | 126 | 2 | 28263956 | |
| Pubmed | 7.01e-04 | 11 | 126 | 2 | 11483621 | ||
| Pubmed | 7.01e-04 | 11 | 126 | 2 | 26403076 | ||
| Pubmed | 7.12e-04 | 529 | 126 | 8 | 14621295 | ||
| Pubmed | SHANK1 BICD2 HECTD4 NCKAP5 SYNPO EXTL3 MED13L TRIP11 MTMR10 CLPB TAF1 AGTPBP1 RPL13 | 8.08e-04 | 1285 | 126 | 13 | 35914814 | |
| Pubmed | A family of 12 human genes containing oxysterol-binding domains. | 8.39e-04 | 12 | 126 | 2 | 11735225 | |
| Pubmed | 8.39e-04 | 12 | 126 | 2 | 26929452 | ||
| Pubmed | An oxysterol-binding protein family identified in the mouse. | 8.39e-04 | 12 | 126 | 2 | 12215260 | |
| Pubmed | 8.90e-04 | 421 | 126 | 7 | 36976175 | ||
| Pubmed | 9.89e-04 | 13 | 126 | 2 | 8012115 | ||
| Pubmed | Requirement of tissue-selective TBP-associated factor TAFII105 in ovarian development. | 9.89e-04 | 13 | 126 | 2 | 11557891 | |
| Pubmed | Rps4 maps near the inactivation center on the mouse X chromosome. | 9.89e-04 | 13 | 126 | 2 | 1740345 | |
| Pubmed | 9.89e-04 | 13 | 126 | 2 | 29499138 | ||
| Pubmed | XIST and the mapping of the X chromosome inactivation centre. | 9.89e-04 | 13 | 126 | 2 | 1772416 | |
| Pubmed | 9.89e-04 | 13 | 126 | 2 | 33374598 | ||
| Pubmed | 9.89e-04 | 13 | 126 | 2 | 7805729 | ||
| GeneFamily | Sterile alpha motif domain containing | 4.65e-04 | 88 | 74 | 4 | 760 | |
| GeneFamily | Oxysterol binding proteins|Pleckstrin homology domain containing | 1.06e-03 | 12 | 74 | 2 | 670 | |
| GeneFamily | Solute carriers | 1.15e-03 | 395 | 74 | 7 | 752 | |
| Coexpression | GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN | 5.28e-06 | 199 | 125 | 8 | M6264 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.18e-06 | 190 | 126 | 7 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.32e-06 | 193 | 126 | 7 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-06 | 198 | 126 | 7 | b3a020522e064bb61949d38e442f24026e339364 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-06 | 198 | 126 | 7 | fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.75e-06 | 152 | 126 | 6 | ca23261d8ef263cc697b8d7e7cb2afec8bc564f2 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.38e-06 | 160 | 126 | 6 | 19105debef96ea0c267d6a1d332303ec668ae47e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.72e-06 | 169 | 126 | 6 | c7fc3a8c44f07c557b60d469717b66e2f5863d38 | |
| ToppCell | Leuk-UTI-Myeloid-cDC1|Leuk-UTI / Disease, Lineage and Cell Type | 9.96e-06 | 173 | 126 | 6 | 226bb8d881f32d65c60f5e4c034c6d465f8e7ba5 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.06e-05 | 175 | 126 | 6 | 2812ac2ef41d245db544697fb6da1883361c96e8 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-05 | 175 | 126 | 6 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-05 | 175 | 126 | 6 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 183 | 126 | 6 | 709a486154b3157427deb3b8886b63ac39ea42dd | |
| ToppCell | droplet-Liver-nan-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 183 | 126 | 6 | dc06f19f6f80f4c7f13f1f990c1fe0f91ba64ea7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 183 | 126 | 6 | dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 183 | 126 | 6 | 4759560e5b4f4e5a00e5f933e3451a27c7c4aefe | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.46e-05 | 185 | 126 | 6 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.46e-05 | 185 | 126 | 6 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.50e-05 | 186 | 126 | 6 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 1.55e-05 | 187 | 126 | 6 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 1.70e-05 | 190 | 126 | 6 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.75e-05 | 191 | 126 | 6 | dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 192 | 126 | 6 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-05 | 193 | 126 | 6 | 826b8dd801298b3e0cd76232feae5a14026b8806 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-05 | 193 | 126 | 6 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-05 | 193 | 126 | 6 | 87d3a577d37fb0cb4b6313c596310de452bc3872 | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.85e-05 | 193 | 126 | 6 | 479abb1cd2eb978b8a4fdb900069a6329fc8cade | |
| ToppCell | 10x5'v1-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.91e-05 | 194 | 126 | 6 | e141beafc9252e5d8c949252bfab53e127c881dc | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.91e-05 | 194 | 126 | 6 | 953578102ffc7b612ee8fce45e414750800fef5d | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Acinar_Adenocarcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.91e-05 | 115 | 126 | 5 | eae0227fbdffe41656d924d74dc885d7f5d5f73d | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.96e-05 | 195 | 126 | 6 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-05 | 195 | 126 | 6 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.99e-05 | 116 | 126 | 5 | f32f7eddfe33adb3b5cf7c34667a481a305c5163 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 196 | 126 | 6 | 7cbb19108b4553ef60ef5c230a29de1662c02efe | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 196 | 126 | 6 | 4cd1e6b7a791e11a40b19f971b7011bd11fe6273 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 196 | 126 | 6 | d37f714d4fb57e958f3738fdda085560813e5bb5 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.02e-05 | 196 | 126 | 6 | b71b197cb92117dd9efaa13de000841901cc4ca8 | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 2.02e-05 | 196 | 126 | 6 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-05 | 197 | 126 | 6 | c10dd1aaec01fb662eac83dfde90e3e426665d65 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-05 | 197 | 126 | 6 | 2844dbcd0a673ed81c99920aa45858651a00736d | |
| ToppCell | tumor_Lung-Endothelial_cells-Tumor_ECs|tumor_Lung / Location, Cell class and cell subclass | 2.14e-05 | 198 | 126 | 6 | 5228c4bf2513186140c2c4eaa67a268c732bdc84 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.14e-05 | 198 | 126 | 6 | 9ab0db78394e730f6866b2db80047149024ad5f6 | |
| ToppCell | 5'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.14e-05 | 198 | 126 | 6 | 90e85fe7a0ab376a41666dfff6c0e95b7f1c9475 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.14e-05 | 198 | 126 | 6 | e47d0e2c6353315c85d7007742bb16b0f05795ed | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.20e-05 | 199 | 126 | 6 | dc88ce36cc066eb6c28cfd5b9b60fe07f8cc7b53 | |
| ToppCell | Caecum-(5)_Dendritic_cell-(51)_cDC1|Caecum / shred on region, Cell_type, and subtype | 2.20e-05 | 199 | 126 | 6 | 2b97fda45241b2ce7be904cf081cabcf3eb5ba1d | |
| ToppCell | Caecum-Dendritic_cell-cDC1|Caecum / Region, Cell class and subclass | 2.20e-05 | 199 | 126 | 6 | 9ab38a0060a883de6fe3da8cdac42e124d7981d9 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal|10w / Sample Type, Dataset, Time_group, and Cell type. | 2.26e-05 | 200 | 126 | 6 | 979258173b82f37aeaaedd53b4a527da1dbe1b80 | |
| ToppCell | COVID-19_Mild-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 2.74e-05 | 124 | 126 | 5 | 5ef9eb806fb2c8ee5aae0a75503d244b08ee10d4 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Angpt2_(Angpt2)--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.40e-05 | 69 | 126 | 4 | 73b7accba3060705dcd6240e0ff47d68f2014ddd | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Angpt2_(Angpt2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.40e-05 | 69 | 126 | 4 | 4e2e86e1da2ded562252774dc49e1b0b4274259f | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Angpt2_(Angpt2)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.40e-05 | 69 | 126 | 4 | 3b1b8b8f85440a7a88d52969bdff384a0c1a5470 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.24e-05 | 142 | 126 | 5 | 819e983688d126d89a71abc03d72525cc759a347 | |
| ToppCell | VE-Treg-naive_CD4|VE / Condition, Cell_class and T cell subcluster | 8.19e-05 | 156 | 126 | 5 | 6501baf73616e702946de9fb13d267e30a68888b | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.96e-05 | 159 | 126 | 5 | 7cda111bb98f1241989e49d490bdf51a712ea589 | |
| ToppCell | VE-mono3|VE / Condition, Cell_class and T cell subcluster | 9.50e-05 | 161 | 126 | 5 | 7df3fefc55ab43b897fc78d1f0c7383b10ac33d5 | |
| ToppCell | VE-mono3-|VE / Condition, Cell_class and T cell subcluster | 9.50e-05 | 161 | 126 | 5 | 4e45bf7eceb0ee30dec4d8852778366776ea5a8f | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P2|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.51e-05 | 84 | 126 | 4 | 1f8b19b159f83655f66cb99f8d10d9a87c08f78f | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4_(Bmp4)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.51e-05 | 84 | 126 | 4 | c37e1170d39ad015f724e373a547ea5b6ba45a84 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4_(Bmp4)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.51e-05 | 84 | 126 | 4 | 7e4a76b65b0d34d9950f8b02590ff5a4b4534a27 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P2-Tnr|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.51e-05 | 84 | 126 | 4 | 503490e9408d9638bcd089ef8ec0521924df9a5d | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 163 | 126 | 5 | 953a7db7e90a913e81002d2141fbbd5f1fdf2197 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 165 | 126 | 5 | a74751e0ec857aa974bec04ccc747c004a8f6e01 | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.13e-04 | 167 | 126 | 5 | 97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D122|Adult / Lineage, Cell type, age group and donor | 1.16e-04 | 168 | 126 | 5 | 8c3e1e45b422813bcdfa4273b1167db649a312f5 | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.19e-04 | 89 | 126 | 4 | a4c2e364f8017dd9631f5ef06bdabdb2ebed1db8 | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.19e-04 | 89 | 126 | 4 | c9c3fce307f14e90cc0d24e9611c454010a60869 | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.19e-04 | 89 | 126 | 4 | 2e5da863e68a8fe378a34b67e4703013b731a7a4 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-04 | 170 | 126 | 5 | 3a7121d045f9ae54583b0f5f7436abf3665a1bce | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.23e-04 | 170 | 126 | 5 | adb625124832b0786a590e8f75b61e7263a1e0d4 | |
| ToppCell | Endothelial-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.30e-04 | 172 | 126 | 5 | d4e98ff9c7cbc95457e1d71fa60f151a2f178dae | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-04 | 173 | 126 | 5 | f193c63cc536d891c9d23043765e320252bb6e65 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.33e-04 | 173 | 126 | 5 | 85083b9ce20351dd69aa2327ad087b848b4307ff | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.37e-04 | 174 | 126 | 5 | feed99acd868db61f045e666dbfdcaed91ca1488 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma-4|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.40e-04 | 175 | 126 | 5 | 16849ea8f0985108baa2085f34c3de14a4f9f28b | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 1.44e-04 | 176 | 126 | 5 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.44e-04 | 176 | 126 | 5 | 95d5a4fdff1b9c715636684d22e06f8727ac0e7a | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 1.44e-04 | 176 | 126 | 5 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | Control|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 177 | 126 | 5 | b8ff6940e31b749776e81ae4f5bbd577dba9749c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 178 | 126 | 5 | 5f779a66aa42d1d8e8af17b4a08d5dcc733efd4c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.56e-04 | 179 | 126 | 5 | ba64bfb757d6e3be631ee95abfa24b47861f6a14 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 181 | 126 | 5 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-04 | 181 | 126 | 5 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 181 | 126 | 5 | a53f05c4c47465ee62e353716456bd09ab464b23 | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.64e-04 | 181 | 126 | 5 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 182 | 126 | 5 | dc55de945c6f78f32eb3a1b3520835eb8417e068 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 182 | 126 | 5 | 010a7364da46101cb5068891fd7bc712ea8f13bd | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 182 | 126 | 5 | b1ec2015aad1181eac1bbf8d48ad6f2f7ed24a01 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.73e-04 | 183 | 126 | 5 | ba43bca2b45be1008eebd3f033cecb061fb3a966 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.73e-04 | 183 | 126 | 5 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-DC1|Lung / Manually curated celltypes from each tissue | 1.73e-04 | 183 | 126 | 5 | e4cbd39575b5a4612d9934532e3bad63286f8aa5 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_pre-Lymphocytic-T|lymph-node_spleen / Manually curated celltypes from each tissue | 1.73e-04 | 183 | 126 | 5 | 6c55fd737ed31f5b1aa41dc4dba7240521c19022 | |
| ToppCell | COPD-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 1.77e-04 | 184 | 126 | 5 | 42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94 | |
| ToppCell | critical-Epithelial-Ionocyte|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.77e-04 | 184 | 126 | 5 | 58d36577eff814d46d72f031f3533d71549e3d6e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 184 | 126 | 5 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | (7)_DC_activated|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.77e-04 | 184 | 126 | 5 | b89871a3e36fde6daa68daf116f8c8d587554c0f | |
| ToppCell | COVID-cycling-|COVID / Condition, Cell_class and T cell subcluster | 1.82e-04 | 185 | 126 | 5 | eb74b8d36f7b749e04bc2ed4b36f7e1ac7bb6d5f | |
| ToppCell | COVID-cycling|COVID / Condition, Cell_class and T cell subcluster | 1.82e-04 | 185 | 126 | 5 | 5112f966735fa48f0606adcfd5c0212ad5d3d77a | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(other)|Control / group, cell type (main and fine annotations) | 1.86e-04 | 186 | 126 | 5 | c6075fe84226b370c5139066793844ad33ae2db1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-04 | 186 | 126 | 5 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.86e-04 | 186 | 126 | 5 | 2e024097ee361eeb1d855a4edb8ac8cdad35da06 | |
| Disease | MYELODYSPLASTIC SYNDROME | 1.64e-04 | 67 | 120 | 4 | C3463824 | |
| Disease | cytotoxicity measurement, response to clozapine | 2.22e-04 | 29 | 120 | 3 | EFO_0006952, GO_0097338 | |
| Disease | diastolic blood pressure, unipolar depression | 2.46e-04 | 30 | 120 | 3 | EFO_0003761, EFO_0006336 | |
| Disease | proteinuria (implicated_via_orthology) | 2.46e-04 | 30 | 120 | 3 | DOID:576 (implicated_via_orthology) | |
| Disease | reaction time measurement | TNIK BICD2 SH2B3 WDR7 HECTD4 NCKAP5 MED13L SLC35D1 PTPRO CDH2 | 3.66e-04 | 658 | 120 | 10 | EFO_0008393 |
| Disease | myelofibrosis (is_implicated_in) | 4.52e-04 | 8 | 120 | 2 | DOID:4971 (is_implicated_in) | |
| Disease | body mass index, coronary artery disease | 4.52e-04 | 8 | 120 | 2 | EFO_0001645, EFO_0004340 | |
| Disease | cardiovascular disease | 5.77e-04 | 457 | 120 | 8 | EFO_0000319 | |
| Disease | hearing impairment | 7.00e-04 | 98 | 120 | 4 | C1384666 | |
| Disease | Fanconi anemia (is_implicated_in) | 7.23e-04 | 10 | 120 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | forced expiratory volume, body mass index | 8.81e-04 | 11 | 120 | 2 | EFO_0004314, EFO_0004340 | |
| Disease | diabetic maculopathy | 1.05e-03 | 12 | 120 | 2 | EFO_0010133 | |
| Disease | hair colour measurement, hair morphology measurement | 1.05e-03 | 12 | 120 | 2 | EFO_0007821, EFO_0007822 | |
| Disease | skin melanoma (is_implicated_in) | 1.45e-03 | 14 | 120 | 2 | DOID:8923 (is_implicated_in) | |
| Disease | Fanconi anemia | 1.45e-03 | 14 | 120 | 2 | cv:C0015625 | |
| Disease | Ischemic stroke, fibrinogen measurement | 1.48e-03 | 55 | 120 | 3 | EFO_0004623, HP_0002140 | |
| Disease | BMI-adjusted adiponectin measurement | 1.66e-03 | 15 | 120 | 2 | EFO_0007737 | |
| Disease | Ischemic stroke, tissue plasminogen activator measurement | 1.66e-03 | 15 | 120 | 2 | EFO_0004791, HP_0002140 | |
| Disease | fibrinogen measurement, factor VII measurement | 1.72e-03 | 58 | 120 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | celiac disease | 1.78e-03 | 126 | 120 | 4 | EFO_0001060 | |
| Disease | Ischemic stroke, plasminogen activator inhibitor 1 measurement | 1.90e-03 | 16 | 120 | 2 | EFO_0004792, HP_0002140 | |
| Disease | caudal anterior cingulate cortex volume measurement | 2.14e-03 | 17 | 120 | 2 | EFO_0010289 | |
| Disease | factor XI measurement, Ischemic stroke | 2.14e-03 | 17 | 120 | 2 | EFO_0004694, HP_0002140 | |
| Disease | Bone marrow hypocellularity | 2.40e-03 | 18 | 120 | 2 | C1855710 | |
| Disease | venous thromboembolism, fibrinogen measurement | 2.60e-03 | 67 | 120 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | Juvenile Myelomonocytic Leukemia | 2.68e-03 | 19 | 120 | 2 | C0349639 | |
| Disease | factor VIII measurement, Ischemic stroke | 2.68e-03 | 19 | 120 | 2 | EFO_0004630, HP_0002140 | |
| Disease | skin pigmentation | 2.83e-03 | 69 | 120 | 3 | EFO_0003784 | |
| Disease | Adenocarcinoma of prostate | 2.97e-03 | 20 | 120 | 2 | C0007112 | |
| Disease | Disproportionate short stature | 3.85e-03 | 77 | 120 | 3 | C0878659 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LVFSKEPSKPLAPRI | 321 | Q9H6B1 | |
| LASLLPFPPDIISKL | 51 | A9YTQ3 | |
| PEPCSASLLLKKVPL | 1196 | Q8WWN8 | |
| RSPILLPKGLLAPEA | 581 | Q8TD16 | |
| PALPLKTRSTPEFSL | 276 | Q05D32 | |
| KSDRDKPLPPLLARV | 1401 | Q8TDI0 | |
| RSISEIKPPNLFPLA | 526 | P49902 | |
| LDFDPLLSPASPKRR | 11 | Q53H80 | |
| ILSLLRDPSKRKVPP | 316 | Q92685 | |
| TRPQLLFSLPKLSPS | 161 | Q14094 | |
| ALRLPPTSLKPDTFR | 96 | Q9GZQ3 | |
| SPKSAILPEPLLKSI | 456 | Q9P1A6 | |
| PASFLLLIQKDLPPL | 451 | Q17RM4 | |
| LPKCERLPLPSFLLL | 541 | O94989 | |
| LEPPPTTLRKAFLAQ | 46 | Q3SXR2 | |
| FPKNRLPLPTIKSSF | 326 | Q9UPW5 | |
| SPSSLRALKEPLLPD | 1166 | Q8IXJ9 | |
| KLFLAPKPAPVLESS | 601 | Q13367 | |
| GPLTSRALLVLPPLK | 201 | Q6P387 | |
| PKTLGKLPTLPARLN | 341 | Q8TBY0 | |
| RPRPRKPSFLKALLA | 291 | O15438 | |
| PFSLPFLKRLTLIKP | 296 | Q96LL4 | |
| FLPETLPLEKRAPSI | 221 | Q14728 | |
| HPFLKLAKPLSSLTP | 531 | O75914 | |
| RLSKALFPPEPLVLR | 221 | Q96AD5 | |
| KEFSLEPPSRPLVLK | 671 | Q8NG48 | |
| LLPLKIPDACLFRPS | 961 | Q71F56 | |
| LLSPLLPSIKPTVRK | 1066 | Q14676 | |
| SPARGLKFLKLPPTS | 451 | Q9HCH0 | |
| LLPRRNSLILKPKPD | 601 | Q9NXD2 | |
| LSAALRSLPAEKPPA | 2481 | Q9UKN7 | |
| ALLHIFSRKPPEKPL | 116 | Q86YD7 | |
| APRALSLLSLPPKKR | 246 | Q4VC44 | |
| SLPQPFLLSLRKRSP | 276 | Q8NAA5 | |
| FTLVLKDRSPLLPGP | 276 | A6NM62 | |
| STHQFKKLLSLPPLP | 256 | Q9UPZ3 | |
| LKPPCRLVELLPFSS | 11 | O43261 | |
| FFPISKDQPRVLLPL | 56 | Q13144 | |
| SKLFPKIPPHSLRVL | 206 | P42356 | |
| PLLTFPSKEPLRSVL | 831 | P42356 | |
| AIRLELFLPPQLKPA | 151 | Q8TD35 | |
| VDSFLPLLKSPLAAP | 881 | Q92616 | |
| PLAAPRIKNPFLSLA | 891 | Q92616 | |
| LLLRRPLPPKFTKLS | 6 | Q05C16 | |
| PLPLDLLPSFWKTLV | 3716 | Q9Y4D8 | |
| TKLPLSLDLPSPRPF | 581 | Q3MIN7 | |
| VLKDLLPPTDARFRP | 841 | Q9BZF3 | |
| FLRPESGSLPALKPL | 136 | Q969R2 | |
| TPRKDLPPLLLKLNE | 686 | Q9H0A0 | |
| LKRPKRPLFNFALVP | 71 | Q96RW7 | |
| LRLVKLEPAPPKSLF | 716 | Q16827 | |
| AAASLPPLPRKVLFV | 86 | Q53T59 | |
| LPRISSLPKSEKPLN | 446 | P51587 | |
| LPDIEPSPLRTFKAF | 121 | Q7Z4J2 | |
| LPFSLKANRPPLEVL | 241 | Q9NQL9 | |
| SILKPLLPTPDLTLK | 516 | Q6P1L5 | |
| PKLSLPIRLLPEKDD | 151 | O43909 | |
| SHFLPALLTPRVLPK | 581 | O15360 | |
| KTLKPTLFPAVPRLL | 341 | Q9ULC5 | |
| DKLPIFPDSARLPLT | 11 | Q9NQ33 | |
| FASKTPRPVTEPLLL | 36 | Q6GMR7 | |
| RDIASKKPLLSPIPE | 581 | Q69YH5 | |
| VPADKARSPAVPLLL | 81 | Q92837 | |
| LPSPQAEKRLPKLRL | 666 | Q9H078 | |
| PLGSLLDRLKPPLAD | 441 | Q9HBE5 | |
| PLLSNIRPDFSKAPL | 161 | Q8WTZ4 | |
| SRPLPKILLTSAAPK | 71 | P34741 | |
| TPLALKQLPKPRTSL | 86 | P0C263 | |
| PFAFDLPLSPVTIKR | 636 | P19022 | |
| SGRSIKFLLPPLSLL | 201 | Q56UN5 | |
| KFLLPPLSLLPTRSG | 206 | Q56UN5 | |
| RSKLILFPRKPSAPK | 121 | P26373 | |
| PPEDRLSLKFLPSSE | 71 | Q6PGQ1 | |
| SSPVLLKLLFSPGPK | 11 | Q6ZNG9 | |
| ESLLTPRLAPSKPFT | 1776 | Q16363 | |
| LRLKAPFSELPFLPL | 261 | Q9BQI9 | |
| SPPSIIDKLFLDTLP | 611 | Q92570 | |
| KLAELPPTPLRATAK | 776 | Q8NEY1 | |
| FPVPSASPKRRSKLL | 56 | Q2WGJ9 | |
| PPAEKLVLTRFLPLQ | 111 | Q8N9W8 | |
| PPLRPILKKTASLGF | 296 | Q9BZD2 | |
| GRVKLLSPSILKPFP | 666 | O95602 | |
| SKRPLPLEPLLFLQV | 11 | Q8TBZ9 | |
| SNLIPKLFRPAAFLP | 101 | Q6P4A7 | |
| ISSPLFGLLSDKRPP | 286 | Q6NT16 | |
| RTPFKSPLLKGISAP | 966 | O14513 | |
| SKLPLRIPPKSEGLL | 1366 | O14513 | |
| FSLETKLPLSPPLVE | 11 | O96007 | |
| LSLKTPSERLLYPLP | 261 | E9PKD4 | |
| PDTLPSPEALKFKIL | 281 | Q86YW0 | |
| LRPSLFVLSPIKEPA | 811 | Q8N3V7 | |
| KLLPSVTELFPEFRP | 241 | Q8IZX4 | |
| KLLPSVTELFPEFRP | 221 | P21675 | |
| SRSDPFTLNLLPKLP | 226 | Q9UQ74 | |
| AFAELRKLLPTLPPD | 96 | Q02577 | |
| LDRNVPRKTFPLPLL | 101 | Q9NTN3 | |
| PSPSKGPLRALVLLL | 156 | Q9NP94 | |
| LSPTRLLSLPPDKPF | 2076 | Q9Y566 | |
| LLLPPSSSELKAGRP | 71 | Q9UM73 | |
| SLFPLLFTAPELPIK | 416 | Q9BVK2 | |
| RIAEAATLKPPPFLR | 251 | Q9GZX3 | |
| APSKARKLLPVLDPS | 16 | Q8IV77 | |
| LELLAPKSRSPSPGK | 866 | Q15735 | |
| LKPIFPLILSDDPTS | 156 | Q96PP4 | |
| VPPKLPSSLRKLFLS | 216 | Q9NR97 | |
| PPLKASLSLRKEPVA | 266 | Q9UM82 | |
| ALFLIPRNPAPRLKS | 241 | Q9UKE5 | |
| PFPIKPLSESKNRLL | 321 | Q5W0Z9 | |
| PSKSSIIPFRALKRP | 311 | Q7Z7L7 | |
| KALISFLEPKLPARP | 286 | Q9C0A1 | |
| LLISADNKPPPRLLS | 181 | Q96EK2 | |
| RDLLLPSPVSALKPL | 1066 | Q9BYB0 | |
| LSFKVPFLPVLPILS | 556 | P30825 | |
| RALLVPPKAKPFLSN | 796 | A1X283 | |
| LLKIAKSDPPTLLTP | 246 | O94804 | |
| LLSAARLFKLPPGPE | 1231 | O94885 | |
| PKSLPSERILPALSK | 611 | P19634 | |
| VLELFDPPKSSRPKL | 236 | Q9UQQ2 | |
| GKPLLRFPTALVLDP | 721 | Q9Y4R7 | |
| LSLFPASPRARPKEL | 36 | Q53GA4 | |
| ATLEKKLPPLPLTLA | 326 | O96008 | |
| LLLKPISDVLPTFTP | 1946 | Q15643 | |
| LAVSLKPPFLRPELL | 261 | Q9ULC8 | |
| SLTKLPFPLSPILLS | 76 | Q8N0V1 | |
| LSKLVLSAGPLRPTP | 36 | Q5HYJ1 | |
| CKALTFLLLQPPSPK | 1176 | Q9Y4E6 | |
| IFAPKSLPPSRLLLL | 66 | Q7Z769 | |
| ALLLTASERPKPLLF | 166 | Q9NYU2 | |
| LPKPLKSQASLLSLP | 71 | Q8WZ26 | |
| AKLLLPTLSSLAFLP | 6 | A6NI61 | |
| ATEPKKLPFPLSTLA | 381 | Q9NQS3 |